These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 27481108)

  • 1. Reduced potency of cytotoxic T lymphocytes from patients with high-risk myelodysplastic syndromes.
    Sand K; Theorell J; Bruserud Ø; Bryceson YT; Kittang AO
    Cancer Immunol Immunother; 2016 Sep; 65(9):1135-47. PubMed ID: 27481108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro deprivation of CD8(+)CD57(+)T cells promotes the malignant growth of bone marrow colony cells in patients with lower-risk myelodysplastic syndrome.
    Zheng Z; Qianqiao Z; Qi H; Feng X; Chunkang C; Xiao L
    Exp Hematol; 2010 Aug; 38(8):677-84. PubMed ID: 20394797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apoptotic cells and clonally expanded cytotoxic T cells in bone marrow trephines of patients with myelodysplastic syndrome.
    Pülhorn H; Herrmann M; Harms H; Jung A; Baumann I
    Histopathology; 2012 Aug; 61(2):200-11. PubMed ID: 22690734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone marrow CD3
    Leone S; Rubino V; Palatucci AT; Giovazzino A; Carriero F; Cerciello G; Pane F; Ruggiero G; Terrazzano G
    Eur J Haematol; 2022 Oct; 109(4):398-405. PubMed ID: 35775392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum-free generation and quantification of functionally active Leukemia-derived DC is possible from malignant blasts in acute myeloid leukemia and myelodysplastic syndromes.
    Kufner S; Fleischer RP; Kroell T; Schmid C; Zitzelsberger H; Salih H; de Valle F; Treder W; Schmetzer HM
    Cancer Immunol Immunother; 2005 Oct; 54(10):953-70. PubMed ID: 15789235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Changes of natural kill cell in peripheral blood of patients with myelodysplastic syndrome].
    Mi H; Fu R; Wang H; Qu W; Ruan E; Wang X; Wang G; Liu H; Wu Y; Song J; Xing L; Guan J; Li L; Jiang H; Zhang W; Yue L; Shao Z
    Zhonghua Yi Xue Za Zhi; 2014 Mar; 94(10):737-41. PubMed ID: 24844955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defective cytotoxicity of T lymphocytes in myelodysplastic syndrome.
    Cukrová V; Neuwirtová R; Dolezalová L; Belicková M; Bartůnková J; Jonásová A; Cermák J; Homolková H; Malíková I
    Exp Hematol; 2009 Mar; 37(3):386-94. PubMed ID: 19136196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased cytotoxic T cells with effector phenotype in aplastic anemia and myelodysplasia.
    Kook H; Zeng W; Guibin C; Kirby M; Young NS; Maciejewski JP
    Exp Hematol; 2001 Nov; 29(11):1270-7. PubMed ID: 11698122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Th17 Cells Exhibit Antitumor Effects in MDS Possibly through Augmenting Functions of CD8+ T Cells.
    Li J; Yue L; Wang H; Liu C; Liu H; Tao J; Qi W; Wang Y; Zhang W; Fu R; Shao Z
    J Immunol Res; 2016; 2016():9404705. PubMed ID: 27722177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune-mediated bone marrow failure syndromes of progenitor and stem cells: molecular analysis of cytotoxic T cell clones.
    Maciejewski JP; O'Keefe C; Gondek L; Tiu R
    Folia Histochem Cytobiol; 2007; 45(1):5-14. PubMed ID: 17378239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patients with myelodysplastic syndromes display several T-cell expansions, which are mostly polyclonal in the CD4(+) subset and oligoclonal in the CD8(+) subset.
    Fozza C; Contini S; Galleu A; Simula MP; Virdis P; Bonfigli S; Longinotti M
    Exp Hematol; 2009 Aug; 37(8):947-55. PubMed ID: 19409953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune responses to WT1 in patients with AML or MDS after chemotherapy and allogeneic stem cell transplantation.
    Casalegno-Garduño R; Schmitt A; Spitschak A; Greiner J; Wang L; Hilgendorf I; Hirt C; Ho AD; Freund M; Schmitt M
    Int J Cancer; 2016 Apr; 138(7):1792-801. PubMed ID: 26519872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD8high (CD57+) T cells in normal, healthy individuals specifically suppress the generation of cytotoxic T lymphocytes to Epstein-Barr virus-transformed B cell lines.
    Wang EC; Lehner PJ; Graham S; Borysiewicz LK
    Eur J Immunol; 1994 Nov; 24(11):2903-9. PubMed ID: 7525311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. WT1-specific CD8 + cytotoxic T cells with the capacity for antigen-specific expansion accumulate in the bone marrow in MDS.
    Suwabe T; Shibasaki Y; Sato H; Tamura S; Katagiri T; Nemoto H; Kasami T; Kozakai T; Nanba A; Kitajima T; Fuse K; Ushiki T; Sone H; Narita M; Masuko M
    Int J Hematol; 2021 May; 113(5):723-734. PubMed ID: 33502734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A perforin/granzyme-positive MDS-derived T cell line, K2-MDS, induces apoptosis in CD34+ cells through the fractalkine-CX3CR1 system.
    Morita Y; Matsuda M; Hanamoto H; Shimada T; Tatsumi Y; Maeda Y; Kanamaru A
    Clin Immunol; 2004 Oct; 113(1):109-16. PubMed ID: 15380536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of T lymphocyte subsets in aplastic anemia and hypoplastic myelodysplastic syndromes.
    Zhang HF; Huang ZD; Wu XR; Li Q; Yu ZF
    Life Sci; 2017 Nov; 189():71-75. PubMed ID: 28935248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Changes and clinical significance of CD8(+) T cell subset in patients with aplastic anemia, myelodysplastic syndrome and acute myeloid leukemia].
    Zhang JY; Xu HZ; Yin DM; Feng XM; Sui XH; Cui B; Ma CY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Feb; 21(1):203-8. PubMed ID: 23484720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Auto- and alloreactivity of T lymphocytes in myelodysplastic syndrome].
    Cukrová V; Neuwirtová R; Bartůnková J; Jonásová A; Cermák J; Homolková H; Malíková I
    Cas Lek Cesk; 2006; 145(8):647-52; discussion 653. PubMed ID: 16995421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preferential suppression of trisomy 8 compared with normal hematopoietic cell growth by autologous lymphocytes in patients with trisomy 8 myelodysplastic syndrome.
    Sloand EM; Mainwaring L; Fuhrer M; Ramkissoon S; Risitano AM; Keyvanafar K; Lu J; Basu A; Barrett AJ; Young NS
    Blood; 2005 Aug; 106(3):841-51. PubMed ID: 15827127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation and ex vivo expansion of cytotoxic T lymphocytes directed toward different types of leukemia or myelodysplastic cells using both HLA-matched and partially matched donors.
    Montagna D; Maccario R; Montini E; Tonelli R; Lisini D; Pagani S; Comoli P; Moretta A; Assirelli E; Basso S; Vitiello A; Pession A; Locatelli F
    Exp Hematol; 2003 Nov; 31(11):1031-8. PubMed ID: 14585366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.